Cordlife Group Limited (SGX:P8A)

Market Cap	55.11M
Revenue (ttm)	37.64M
Net Income (ttm)	-11.13M
Shares Out	256.31M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,900
Average Volume	27,340
Open	0.2150
Previous Close	0.2150
Day's Range	0.2150 - 0.2150
52-Week Range	0.1310 - 0.3300
Beta	0.77
RSI	45.96
Earnings Date	Nov 10, 2025

About Cordlife Group

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test ...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 2001
• Employees: 538
• Stock Exchange: Singapore Exchange
• Ticker Symbol: P8A